AmplifiDX Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $100K

  • Investors
  • 12

AmplifiDX General Information

Description

Developer of a molecular point-of-care device designed to provide rapid test results cost-effectively.The company's technology is engineered for fast turnaround and high sensitivity, otherwise only found in laboratory PCR tests a clear and actionable COVID-19 result, the system is linked to mobile devices, and it delivers results in as little as half an hour, enabling users to quickly isolate and stop the spread.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 39655 Eureka Drive
  • Newark, CA 94560
  • United States
+1 (617)
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 39655 Eureka Drive
  • Newark, CA 94560
  • United States
+1 (617)

AmplifiDX Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AmplifiDX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 15-Apr-2026 $100K Completed Generating Revenue
6. Later Stage VC 01-Jun-2025 Completed Generating Revenue
5. Grant 10-Dec-2024 Completed Generating Revenue
4. Grant 15-May-2023 Completed Generating Revenue
3. Grant 01-Jan-2022 Completed Generating Revenue
2. Seed Round 20-Aug-2021 $2M $2.33M Completed Generating Revenue
1. Angel (individual) 22-Jul-2021 $329K $329K Completed Generating Revenue
To view AmplifiDX’s complete valuation and funding history, request access »

AmplifiDX Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
Seed-3
Seed-2 38,156 $0.000010 $1.05 $1.05 1x $1.05 0.59%
Seed-1 50,678 $0.000010 $0.99 $0.99 1x $0.99 0.78%
To view AmplifiDX’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AmplifiDX Patents

AmplifiDX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250389715-A1 Point-of-care bioassay systems and methods of making and using the same Pending 24-Jun-2024
WO-2026006318-A1 Point-of-care bioassay systems and methods of making and using the same Pending 24-Jun-2024

AmplifiDX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AmplifiDX Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beacon Angels Angel Group Minority
Femovate Accelerator/Incubator Minority
National Institute of Biomedical Imaging and Bioengineering Government
National Institutes of Health Government
Avestria Ventures Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

AmplifiDX FAQs

  • When was AmplifiDX founded?

    AmplifiDX was founded in 2020.

  • Where is AmplifiDX headquartered?

    AmplifiDX is headquartered in Newark, CA.

  • What is the size of AmplifiDX?

    AmplifiDX has 3 total employees.

  • What industry is AmplifiDX in?

    AmplifiDX’s primary industry is Diagnostic Equipment.

  • Is AmplifiDX a private or public company?

    AmplifiDX is a Private company.

  • What is AmplifiDX’s current revenue?

    The current revenue for AmplifiDX is .

  • How much funding has AmplifiDX raised over time?

    AmplifiDX has raised $2.33M.

  • Who are AmplifiDX’s investors?

    Beacon Angels, Femovate, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, and Avestria Ventures are 5 of 12 investors who have invested in AmplifiDX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process